Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 248, P. 114483 - 114483
Published: Dec. 27, 2024
Language: Английский
Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 248, P. 114483 - 114483
Published: Dec. 27, 2024
Language: Английский
Lipids in Health and Disease, Journal Year: 2025, Volume and Issue: 24(1)
Published: Jan. 31, 2025
Language: Английский
Citations
2Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: unknown, P. 106622 - 106622
Published: Jan. 1, 2025
Language: Английский
Citations
1FlatChem, Journal Year: 2025, Volume and Issue: unknown, P. 100834 - 100834
Published: Feb. 1, 2025
Language: Английский
Citations
1Chemical Society Reviews, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
An overview of cyanine dye-based phototherapy agents, including the design strategies, relationships between molecular structures and properties, as well applications in photodynamic therapy, photothermal multimodal combined therapy.
Language: Английский
Citations
5International Journal of Thermal Sciences, Journal Year: 2024, Volume and Issue: 204, P. 109242 - 109242
Published: July 1, 2024
Language: Английский
Citations
4Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 678, P. 378 - 392
Published: Aug. 24, 2024
Language: Английский
Citations
4Biochemical and Biophysical Research Communications, Journal Year: 2025, Volume and Issue: 747, P. 151288 - 151288
Published: Jan. 4, 2025
Language: Английский
Citations
0bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 26, 2025
Photothermal therapy (PTT) has emerged as an effective cancer treatment strategy, which utilizes photothermal agents that accumulate at tumor sites and induce localized hyperthermia when irradiated. Near-infrared II (NIR II) fluorophores, such the polymethine cyanine-based dye IR1061, exhibit higher temporal resolution better tissue penetration, thereby making them promising candidates for PTT. However, challenges low water solubility in vivo short circulation times of these dyes limit their biological applications. To address issues, we have developed a biocompatible biodegradable delivery system IR1061 is encapsulated within lipid-coated hydroxyapatite nanoparticles (LHAPNIRs). The lipid shell composed DPPC/cholesterol/DSPE-PEG to retain prevent serum protein adsorption macrophage recognition, would otherwise hinder targeting. Finally, coat functionalized with acidity-triggered rational membrane (ATRAM) peptide efficient specific internalization into cells mildly acidic microenvironment characteristic tumors. facilitated real-time thermal imaging showed potent NIR-light triggered anticancer activity vitro , no noticeable toxicity healthy tissue. Our results demonstrate ATRAM-LHAPNIRs (ALHAPNIRs) combine PTT robust diagnostic capabilities.
Language: Английский
Citations
0Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(3), P. 306 - 306
Published: Feb. 26, 2025
Conventional cancer treatments often have complications and serious side effects, with limited improvements in 5-year survival quality of life. Photothermal therapy (PTT) employs materials that convert light to heat when exposed near-infrared raise the temperature tumor site directly ablate cells, induce immunogenic cell death, improve microenvironment. This has several benefits, including minimal invasiveness, high efficacy, reduced robust targeting capabilities. Beyond just photothermal conversion materials, nanoplatforms significantly contribute PTT by supplying effective bolstering amplify anti-tumor effects. However, effects alone are ultimately need be combined other therapies. narrative review describes recent progress chemotherapy, radiotherapy, photodynamic therapy, immunotherapy, gene gas chemodynamic photoacoustic imaging, starvation multimodal therapy. Studies shown combining can reduce overcome drug resistance. Despite encouraging results, challenges such as optimizing treatment protocols, addressing heterogeneity, overcoming biological barriers remain. paper highlights potential for personalized, approaches outcomes.
Language: Английский
Citations
0European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 117532 - 117532
Published: March 1, 2025
Language: Английский
Citations
0